Zepbound works by mimicking the hormones GLP-1 and GIP
[6] [7] The Edmonton Obesity Staging System (EOSS) classifies obesity severity from stage 0 to stage 4 based on metabolic, physical, and psychological complications rather than BMI alone
formerly polycystic ovary syndrome (PCOS), liraglutide increased butyrate-producing Lachnospiraceae and partially reversed dysbiosis, while semaglutide uniquely increased Helicobacter , the only taxon negatively correlated with body weight (31)
Comparing detailed ingredient sourcing, pharmacy licensing, and quality documentation helps patients understand value beyond headline pricing
TLDR...I made it one month (barely)
Cardiovascular benefits In November 2023, results from the Semaglutide and cardiovascular outcomes in obesity without diabetes (SELECT) trial, funded by Novo Nordisk, revealed that non-diabetic, overweight adults taking semaglutide for more than three years had a 20% lower risk of heart attack, stroke or death resulting from cardiovascular disease[3]